Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus With Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials-Reference-Cited by-同舟云学术

Efficacy and Safety of Finerenone for Prevention of Cardiovascular Events in Type 2 Diabetes Mellitus With Chronic Kidney Disease: A Meta-analysis of Randomized Controlled Trials

Published:2023-01 Issue:1 Volume:81 Page:55-62
ISSN:0160-2446
Container-title:Journal of Cardiovascular Pharmacology
language:en
Short-container-title:

Author:

Yang Shuai,Shen Wen,Zhang Hong-zhou,Wang Chen-xi,Yu Wan-qian,Wu Qing-hua

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Pharmacology

Reference34 articles.

1. Epidemiology of type 2 diabetes—global burden of disease and forecasted trends;Khan;J Epidemiol Glob Health,2020

2. Changing epidemiology of chronic kidney disease as a result of type 2 diabetes mellitus from 1990 to 2017: estimates from global burden of disease 2017;Li;J Diabetes Investig.,2021

3. Nephropathy in patients with type 2 diabetes mellitus;Ritz;N Engl J Med.,1999

4. Kidney disease and increased mortality risk in type 2 diabetes;Afkarian;J Am Soc Nephrol.,2013

5. Hypertension, obesity, diabetes, and heart failure-free survival: the cardiovascular disease lifetime risk pooling project;Ahmad;JACC Heart Fail.,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The significance of finerenone as a novel therapeutic option in diabetic kidney disease: a scoping review with emphasis on cardiorenal outcomes of the finerenone phase 3 trials;Frontiers in Medicine;2024-06-14

2. Renal effects and safety between Asian and non‐Asian chronic kidney disease and type 2 diabetes treated with nonsteroidal mineralocorticoid antagonists;Journal of Diabetes;2024-05-16

3. Mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure: a meta-analysis;European Heart Journal;2023-08-22

4. Cardiometabolic risk management: insights from a European Society of Cardiology Cardiovascular Round Table;European Heart Journal;2023-07-14

5. Research Progress in Finerenone in Cardiovascular Diseases;Cardiovascular Innovations and Applications;2023